Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Exercise and supplement combo tested to fight prediabetes in childhood cancer survivors

NCT ID NCT05023993

First seen Nov 10, 2025 · Last updated Jun 22, 2026 · Updated 28 times

Summary

This pilot study tests whether a home exercise program plus a dietary supplement called nicotinamide riboside (similar to vitamin B3) can improve muscle health and insulin resistance in adult survivors of childhood cancer who have prediabetes. The study includes 20 participants and focuses on whether the program is practical and well-tolerated. If successful, it may lead to larger studies aimed at preventing diabetes in this high-risk group.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALIGNANT SOLID NEOPLASM are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • City of Hope Medical Center

    Duarte, California, 91010, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

nicotinamide riboside (a dietary supplement similar to vitamin B3) and a home exercise program

What this could lead to

If it works, this could point toward a way to help childhood cancer survivors manage prediabetes and improve muscle health.

What could go wrong

This is a very small pilot study (20 people) focused on feasibility, not on proving the treatment works. The results may not apply to everyone, and the supplement or exercise may not show clear benefits.

Conditions

The condition(s) this trial relates to.

cancer hematopoietic and lymphoid system neoplasm prediabetes syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.